📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Boston Scientific postpones launch of LOTUS Edge valve; shares down 1% premarket

Published 11/29/2017, 08:05 AM
© Reuters.  Boston Scientific postpones launch of LOTUS Edge valve; shares down 1% premarket
BSX
-
  • Citing the implementation of manufacturing and design changes, Boston Scientific (NYSE:BSX) will delay the commercialization of its LOTUS Edge Aortic Valve System. It expects to reintroduce the device in Europe next quarter and file the final PMA module in the U.S. by January.
  • The company will update investors on the situation during its Q4 earnings call on February 1, 2018. It says the delay will not have a material impact on its Q4 or full-year guidance.
  • The company voluntarily recalled LOTUS and LOTUS Edge earlier this year on reports of the premature release of a pin connecting the valve to the delivery system.
  • Management will host a conference call this morning at 8:30 am ET to discuss the issue.
  • Shares are off 1% premarket on light volume.
  • Previously: Boston Scientific recalls Lotus Valves due to possible manufacturing defect; shares slump 7% (Feb. 23)
  • Now read: Novocure: Revolutionizing Cancer Treatment


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.